Report cover image

Cell and Gene Therapy Manufacturing Market

Publisher Future Market Insights
Published Jan 18, 2023
Length 250 Pages
SKU # FMARI18797694

Description

Cell and Gene Therapy Manufacturing Market


Global Industry Analysis 2018-2022 and Opportunity Assessment 2023-2033

A recent market study published by FMI on Cell and Gene Therapy Manufacturing offers a global industry analysis for 2018-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

By Therapy Type:
  • Cell Therapy Manufacturing
  • Stem Cell Therapy

  • Non-Stem Cell Therapy
    • Gene Therapy Manufacturing
    By Scale:
    • Pre-commercial/ R&D Manufacturing
    • Commercial Scale Manufacturing
    By Mode:
    • Contract Manufacturing
    • In-house Manufacturing
    By Workflow:
    • Cell Processing
    • Cell Banking
    • Process Development
    • Fill & Finish Operations
    • Analytical And Quality Testing
    • Raw Material Testing
    • Vector Production
    • Other Workflows
    By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • MEA
    Report Chapters

    Executive Summary

    The executive summary of the Cell and Gene Therapy Manufacturing Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Vehicle Radar Test System.

    Chapter 01 - Market Overview

    Readers can find the detailed segmentation and definition of the Cell and Gene Therapy Manufacturing Market in this chapter, which will help to understand basic information about Vehicle Radar Test System. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Cell and Gene Therapy Manufacturing Market report.

    Chapter 02 - Market Background

    This chapter includes detailed analysis of the By Therapy Type processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.

    Chapter 03 - Global Cell and Gene Therapy Manufacturing Market Demand Analysis 2018-2022 and Forecast, 2023-2033

    The chapter include historical market value (US$ 15.6 Billion) analysis (2018-2022) and current and future market value (US$ 19.3 Billion) and volume (29%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.

    Chapter 04 - Global Cell and Gene Therapy Manufacturing Market - Pricing Analysis

    Based on By Therapy Type, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.

    Chapter 05 - Global Cell and Gene Therapy Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Therapy Type

    Based on By Therapy Type, Cell and Gene Therapy Manufacturing Market is segmented into Cell Therapy Manufacturing (Stem Cell Therapy, Non-Stem Cell Therapy), Gene Therapy Manufacturing. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Therapy Type.

    Chapter 06 - Global Cell and Gene Therapy Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Scale

    Based on By Scale, Cell and Gene Therapy Manufacturing Market is segmented into Pre-commercial/ R&D Manufacturing, Commercial Scale Manufacturing. This section also offers market attractiveness analysis based on By Scale. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Scale.

    Chapter 07 - Global Cell and Gene Therapy Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Mode

    Based on By Mode, Cell and Gene Therapy Manufacturing Market is segmented into Contract Manufacturing, In-house Manufacturing. This section also offers market attractiveness analysis based on By Mode. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Mode.

    Chapter 08 - Global Cell and Gene Therapy Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Workflow

    Based on By Workflow, Cell and Gene Therapy Manufacturing Market is segmented into Cell Processing, Cell Banking, Process Development, Fill & Finish Operations, Analytical And Quality Testing, Raw Material Testing, Vector Production, Other Workflows. This section also offers market attractiveness analysis based on By Workflow. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Workflow.

    Chapter 09 - Cell and Gene Therapy Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Region

    Based on By Region, Cell and Gene Therapy Manufacturing Market is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.

    Chapter 10 - North America Cell and Gene Therapy Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033

    This chapter includes a detailed analysis of the growth of the Vehicle Radar Test System in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.

    Chapter 11 - Latin America Cell and Gene Therapy Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033

    This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Cell and Gene Therapy Manufacturing Market in the Latin America region.

    Chapter 12 - Europe Cell and Gene Therapy Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033

    This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Cell and Gene Therapy Manufacturing Market in the regional market.

    Chapter 13 - East Asia Cell and Gene Therapy Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033

    This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Cell and Gene Therapy Manufacturing Market in the regional market.

    Chapter 14 - South Asia Cell and Gene Therapy Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033

    This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Cell and Gene Therapy Manufacturing Market in the regional market.

    Chapter 15 - Middle East and Africa Cell and Gene Therapy Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033

    This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Cell and Gene Therapy Manufacturing Market in the regional market.

    Chapter 16 - Key Countries Cell and Gene Therapy Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033

    This chapter offers insights into how the Cell and Gene Therapy Manufacturing Market is expected to grow in major countries globally.

    Chapter 17 - Market Structure Analysis- Global Assessment

    This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.

    Chapter 18 - Competition Deep Dive (Tentative List)

    This chapter includes company overview, By Therapy Type portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Thermo Fisher Scientific, Merck KGaA, Lonza, Catalent Inc., Takara Bio Inc., F. Hoffmann-La Roche Ltd, Wuxi Advanced Therapies, Samsung Biologics, Boehringer Ingelheim, Novartis AG, Hitachi Chemical Co., Ltd., Cellular Therapeutics, Miltenyi Biotec, Bluebird Bio Inc.

    Chapter 19 - Assumptions and Acronyms

    This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Vehicle Radar Test System report.

    Chapter 20 - Research Methodology

    This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Cell and Gene Therapy Manufacturing Market.

    Table of Contents

    250 Pages
    1. Executive Summary | Cell and Gene Therapy Manufacturing Marke
        1.1. Global Market Outlook
        1.2. Summary of Statistics
        1.3. Key Market Characteristics & Attributes
        1.4. Analysis and Recommendations
    2. Market Overview
        2.1. Market Coverage
        2.2. Market Definition
    3. Market Risks and Trends Assessment
        3.1. Risk Assessment
            3.1.1. COVID-19 Crisis and Impact on Cell And Gene Therapy Manufacturing
            3.1.2. COVID-19 Impact Benchmark with Previous Crisis
            3.1.3. Impact on Market Value (US$ billion)
            3.1.4. Assessment by Key Countries
            3.1.5. Assessment by Key Market Segments
            3.1.6. Action Points and Recommendation for Suppliers
        3.2. Key Trends Impacting the Market
        3.3. Formulation and Product Development Trends
    4. Market Background 
        4.1. Cell And Gene Therapy Manufacturing Market, by Key Countries
        4.2. Opportunity Assessment (US$ billion)
            4.2.1. Total Available Market
            4.2.2. Serviceable Addressable Market
            4.2.3. Serviceable Obtainable Market
        4.3. Market Scenario Forecast
            4.3.1. Demand in optimistic Scenario
            4.3.2. Demand in Likely Scenario
            4.3.3. Demand in Conservative Scenario
        4.4. Investment Feasibility Analysis
            4.4.1. Investment in Established Markets
                4.4.1.1. In Short Term
                4.4.1.2. In Long Term
            4.4.2. Investment in Emerging Markets
                4.4.2.1. In Short Term
                4.4.2.2. In Long Term
        4.5. Forecast Factors - Relevance & Impact
            4.5.1. Top Companies Historical Growth
            4.5.2. Growth in Automation, By Country
            4.5.3. Cell And Gene Therapy Manufacturing Adoption Rate, By Country
        4.6. Market Dynamics
            4.6.1. Market Driving Factors and Impact Assessment
            4.6.2. Prominent Market Challenges and Impact Assessment
            4.6.3. Opportunities
            4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
    5. Key Success Factors
        5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
        5.2. Banking on with Segments High Incremental Opportunity
        5.3. Peer Benchmarking
    6. Global Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033
        6.1. Historical Market Analysis, 2018 to 2022
        6.2. Current and Future Market Projections, 2023 to 2033
        6.3. Y-o-Y Growth Trend Analysis
    7. Global Value Analysis 2018 to 2022 and Forecast, 2023 to 2033
        7.1. Historical Market Value (US$ billion) Analysis, 2018 to 2022
        7.2. Current and Future Market Value (US$ billion) Projections, 2023 to 2033
            7.2.1. Y-o-Y Growth Trend Analysis
            7.2.2. Absolute $ Opportunity Analysis
    8. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Therapy Type
        8.1. Introduction / Key Findings
        8.2. Historical Market Size (US$ billion) Analysis By Therapy Type, 2018 to 2022
        8.3. Current and Future Market Size (US$ billion) Analysis and Forecast By Therapy Type, 2023 to 2033
            8.3.1. Cell Therapy Manufacturing
                8.3.1.1. Stem Cell Therapy
                8.3.1.2. Non-Stem Cell Therapy
            8.3.2. Gene Therapy Manufacturing
        8.4. Market Attractiveness Analysis By Therapy Type
    9. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Scale
        9.1. Introduction / Key Findings
        9.2. Historical Market Size (US$ billion) Analysis By Scale, 2018 to 2022
        9.3. Current and Future Market Size (US$ billion) Analysis and Forecast By Scale, 2023 to 2033
            9.3.1. Pre-commercial/ R&D Scale Manufacturing
            9.3.2. Gene Therapy Manufacturing
        9.4. Market Attractiveness Analysis By Scale
    10. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Mode
        10.1. Introduction / Key Findings
        10.2. Historical Market Size (US$ billion) Analysis By Mode, 2018 to 2022
        10.3. Current and Future Market Size (US$ billion) Analysis and Forecast By Mode, 2023 to 2033
            10.3.1. Contract Manufacturing
            10.3.2. In-house Manufacturing
        10.4. Market Attractiveness Analysis By Mode
    11. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Workflow
        11.1. Introduction / Key Findings
        11.2. Historical Market Size (US$ billion) Analysis By Workflow, 2018 to 2022
        11.3. Current and Future Market Size (US$ billion) Analysis and Forecast By Workflow, 2023 to 2033
            11.3.1. Cell Processing
            11.3.2. Cell Banking
            11.3.3. Process Development
            11.3.4. Fill & Finish Operations
            11.3.5. Analytical And Quality Testing
            11.3.6. Raw Material Testing
            11.3.7. Vector Production
            11.3.8. Other Workflows
        11.4. Market Attractiveness Analysis By Workflow
    12. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
        12.1. Introduction
        12.2. Historical Market Size (US$ billion) Analysis By Region, 2018 to 2022
        12.3. Current Market Size (US$ billion) & Analysis and Forecast By Region, 2023 to 2033
            12.3.1. North America
            12.3.2. Latin America
            12.3.3. Europe
            12.3.4. Asia Pacific
            12.3.5. Middle East and Africa (MEA)
        12.4. Market Attractiveness Analysis By Region
    13. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
        13.1. Introduction
        13.2. Pricing Analysis
        13.3. Historical Market Value (US$ billion) Trend Analysis By Market Taxonomy, 2018 to 2022
        13.4. Market Value (US$ billion) & Forecast By Market Taxonomy, 2023 to 2033
            13.4.1. By Country
                13.4.1.1. United States of America
                13.4.1.2. Canada
                13.4.1.3. Rest of North America
            13.4.2. By Therapy Type
            13.4.3. By Scale
            13.4.4. By Workflow
            13.4.5. By Mode
        13.5. Market Attractiveness Analysis
            13.5.1. By Country
            13.5.2. By Therapy Type
            13.5.3. By Scale
            13.5.4. By Workflow
            13.5.5. By Mode
    14. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
        14.1. Introduction
        14.2. Pricing Analysis
        14.3. Historical Market Value (US$ billion) Trend Analysis By Market Taxonomy, 2018 to 2022
        14.4. Market Value (US$ billion) & Forecast By Market Taxonomy, 2023 to 2033
            14.4.1. By Country
                14.4.1.1. Brazil
                14.4.1.2. Mexico
                14.4.1.3. Rest of Latin America
            14.4.2. By Therapy Type
            14.4.3. By Scale
            14.4.4. By Workflow
            14.4.5. By Mode
        14.5. Market Attractiveness Analysis
            14.5.1. By Country
            14.5.2. By Therapy Type
            14.5.3. By Scale
            14.5.4. By Workflow
            14.5.5. By Mode
    15. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
        15.1. Introduction
        15.2. Pricing Analysis
        15.3. Historical Market Value (US$ billion) Trend Analysis By Market Taxonomy, 2018 to 2022
        15.4. Market Value (US$ billion) & Forecast By Market Taxonomy, 2023 to 2033
            15.4.1. By Country
                15.4.1.1. Germany
                15.4.1.2. France
                15.4.1.3. United Kingdom
                15.4.1.4. Italy
                15.4.1.5. Benelux
                15.4.1.6. Nordic Countries
                15.4.1.7. Rest of Europe
            15.4.2. By Therapy Type
            15.4.3. By Scale
            15.4.4. By Workflow
            15.4.5. By Mode
        15.5. Market Attractiveness Analysis
            15.5.1. By Country
            15.5.2. By Therapy Type
            15.5.3. By Scale
            15.5.4. By Workflow
            15.5.5. By Mode
    16. Asia Pacific Analysis 2018 to 2022 and Forecast 2023 to 2033
        16.1. Introduction
        16.2. Pricing Analysis
        16.3. Historical Market Value (US$ billion) Trend Analysis By Market Taxonomy, 2018 to 2022
        16.4. Market Value (US$ billion) & Forecast By Market Taxonomy, 2023 to 2033
            16.4.1. By Country
                16.4.1.1. China
                16.4.1.2. Japan
                16.4.1.3. South Korea
                16.4.1.4. Rest of Asia Pacific
            16.4.2. By Therapy Type
            16.4.3. By Scale
            16.4.4. By Workflow
            16.4.5. By Mode
        16.5. Market Attractiveness Analysis
            16.5.1. By Country
            16.5.2. By Therapy Type
            16.5.3. By Scale
            16.5.4. By Workflow
            16.5.5. By Mode
    17. Middle East and Africa Analysis 2018 to 2022 and Forecast 2023 to 2033
        17.1. Introduction
        17.2. Pricing Analysis
        17.3. Historical Market Value (US$ billion) Trend Analysis By Market Taxonomy, 2018 to 2022
        17.4. Market Value (US$ billion) & Forecast By Market Taxonomy, 2023 to 2033
            17.4.1. By Country
                17.4.1.1. GCC Countries
                17.4.1.2. South Africa
                17.4.1.3. Turkey
                17.4.1.4. Rest of Middle East and Africa
            17.4.2. By Therapy Type
            17.4.3. By Scale
            17.4.4. By Workflow
            17.4.5. By Mode
        17.5. Market Attractiveness Analysis
            17.5.1. By Country
            17.5.2. By Therapy Type
            17.5.3. By Scale
            17.5.4. By Workflow
            17.5.5. By Mode
    18. Key Countries Analysis 2018 to 2022 and Forecast 2023 to 2033
        18.1. Introduction
            18.1.1. Market Value Proportion Analysis, By Key Countries
            18.1.2. Global Vs. Country Growth Comparison
        18.2. US Analysis
            18.2.1. Value Proportion Analysis by Market Taxonomy
            18.2.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
                18.2.2.1. By Therapy Type
                18.2.2.2. By Scale
                18.2.2.3. By Workflow
                18.2.2.4. By Mode
        18.3. Canada Analysis
            18.3.1. Value Proportion Analysis by Market Taxonomy
            18.3.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
                18.3.2.1. By Therapy Type
                18.3.2.2. By Scale
                18.3.2.3. By Workflow
                18.3.2.4. By Mode
        18.4. Mexico Analysis
            18.4.1. Value Proportion Analysis by Market Taxonomy
            18.4.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
                18.4.2.1. By Therapy Type
                18.4.2.2. By Scale
                18.4.2.3. By Workflow
                18.4.2.4. By Mode
        18.5. Brazil Analysis
            18.5.1. Value Proportion Analysis by Market Taxonomy
            18.5.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
                18.5.2.1. By Therapy Type
                18.5.2.2. By Scale
                18.5.2.3. By Workflow
                18.5.2.4. By Mode
        18.6. Germany Analysis
            18.6.1. Value Proportion Analysis by Market Taxonomy
            18.6.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
                18.6.2.1. By Therapy Type
                18.6.2.2. By Scale
                18.6.2.3. By Workflow
                18.6.2.4. By Mode
        18.7. France Analysis
            18.7.1. Value Proportion Analysis by Market Taxonomy
            18.7.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
                18.7.2.1. By Therapy Type
                18.7.2.2. By Scale
                18.7.2.3. By Workflow
                18.7.2.4. By Mode
        18.8. Italy Analysis
            18.8.1. Value Proportion Analysis by Market Taxonomy
            18.8.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
                18.8.2.1. By Therapy Type
                18.8.2.2. By Scale
                18.8.2.3. By Workflow
                18.8.2.4. By Mode
        18.9. BENELUX Analysis
            18.9.1. Value Proportion Analysis by Market Taxonomy
            18.9.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
                18.9.2.1. By Therapy Type
                18.9.2.2. By Scale
                18.9.2.3. By Workflow
                18.9.2.4. By Mode
        18.10. UK Analysis
            18.10.1. Value Proportion Analysis by Market Taxonomy
            18.10.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
                18.10.2.1. By Therapy Type
                18.10.2.2. By Scale
                18.10.2.3. By Workflow
                18.10.2.4. By Mode
        18.11. Nordic Countries Analysis
            18.11.1. Value Proportion Analysis by Market Taxonomy
            18.11.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
                18.11.2.1. By Therapy Type
                18.11.2.2. By Scale
                18.11.2.3. By Workflow
                18.11.2.4. By Mode
        18.12. China Analysis
            18.12.1. Value Proportion Analysis by Market Taxonomy
            18.12.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
                18.12.2.1. By Therapy Type
                18.12.2.2. By Scale
                18.12.2.3. By Workflow
                18.12.2.4. By Mode
        18.13. Japan Analysis
            18.13.1. Value Proportion Analysis by Market Taxonomy
            18.13.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
                18.13.2.1. By Therapy Type
                18.13.2.2. By Scale
                18.13.2.3. By Workflow
                18.13.2.4. By Mode
        18.14. South Korea Analysis
            18.14.1. Value Proportion Analysis by Market Taxonomy
            18.14.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
                18.14.2.1. By Therapy Type
                18.14.2.2. By Scale
                18.14.2.3. By Workflow
                18.14.2.4. By Mode
        18.15. GCC Countries Analysis
            18.15.1. Value Proportion Analysis by Market Taxonomy
            18.15.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
                18.15.2.1. By Therapy Type
                18.15.2.2. By Scale
                18.15.2.3. By Workflow
                18.15.2.4. By Mode
        18.16. South Africa Analysis
            18.16.1. Value Proportion Analysis by Market Taxonomy
            18.16.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
                18.16.2.1. By Therapy Type
                18.16.2.2. By Scale
                18.16.2.3. By Workflow
                18.16.2.4. By Mode
        18.17. Turkey Analysis
            18.17.1. Value Proportion Analysis by Market Taxonomy
            18.17.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
                18.17.2.1. By Therapy Type
                18.17.2.2. By Scale
                18.17.2.3. By Workflow
                18.17.2.4. By Mode
            18.17.3. Competition Landscape and Player Concentration in the Country
    19. Market Structure Analysis
        19.1. Market Analysis by Tier of Companies
        19.2. Market Concentration
        19.3. Market Share Analysis of Top Players
        19.4. Market Presence Analysis
            19.4.1. By Regional footprint of Players
            19.4.2. Product footprint by Players
    20. Competition Analysis
        20.1. Competition Dashboard
        20.2. Competition Benchmarking
        20.3. Competition Deep Dive
            20.3.1. Thermo Fisher Scientific
                20.3.1.1. Overview
                20.3.1.2. Product Portfolio
                20.3.1.3. Sales Footprint
                20.3.1.4. Strategy Overview
            20.3.2. Merck KGaA
                20.3.2.1. Overview
                20.3.2.2. Product Portfolio
                20.3.2.3. Sales Footprint
                20.3.2.4. Strategy Overview
            20.3.3. Lonza
                20.3.3.1. Overview
                20.3.3.2. Product Portfolio
                20.3.3.3. Sales Footprint
                20.3.3.4. Strategy Overview
            20.3.4. Catalent Inc.
                20.3.4.1. Overview
                20.3.4.2. Product Portfolio
                20.3.4.3. Sales Footprint
                20.3.4.4. Strategy Overview
            20.3.5. Takara Bio Inc.
                20.3.5.1. Overview
                20.3.5.2. Product Portfolio
                20.3.5.3. Sales Footprint
                20.3.5.4. Strategy Overview
            20.3.6. F. Hoffmann-La Roche Ltd
                20.3.6.1. Overview
                20.3.6.2. Product Portfolio
                20.3.6.3. Sales Footprint
                20.3.6.4. Strategy Overview
            20.3.7. Wuxi Advanced Therapies
                20.3.7.1. Overview
                20.3.7.2. Product Portfolio
                20.3.7.3. Sales Footprint
                20.3.7.4. Strategy Overview
            20.3.8. Samsung Biologics
                20.3.8.1. Overview
                20.3.8.2. Product Portfolio
                20.3.8.3. Sales Footprint
                20.3.8.4. Strategy Overview
            20.3.9. Boehringer Ingelheim
                20.3.9.1. Overview
                20.3.9.2. Product Portfolio
                20.3.9.3. Sales Footprint
                20.3.9.4. Strategy Overview
            20.3.10. Novartis AG
                20.3.10.1. Overview
                20.3.10.2. Product Portfolio
                20.3.10.3. Sales Footprint
                20.3.10.4. Strategy Overview
            20.3.11. Hitachi Chemical Co., Ltd.
                20.3.11.1. Overview
                20.3.11.2. Product Portfolio
                20.3.11.3. Sales Footprint
                20.3.11.4. Strategy Overview
            20.3.12. Cellular Therapeutics
                20.3.12.1. Overview
                20.3.12.2. Product Portfolio
                20.3.12.3. Sales Footprint
                20.3.12.4. Strategy Overview
                20.3.12.5. Miltenyi Biotec Overview
                20.3.12.6. Product Portfolio
                20.3.12.7. Sales Footprint
                20.3.12.8. Strategy Overview
            20.3.13. Bluebird Bio Inc.
                20.3.13.1. Overview
                20.3.13.2. Product Portfolio
                20.3.13.3. Sales Footprint
                20.3.13.4. Strategy Overview
    21. Assumptions and Acronyms Used
    22. Research Methodology

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us